会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 2. 发明申请
    • CEPHALOSPORIN DERIVATIVE
    • CEPHALOSPORIN衍生物
    • WO1994022874A1
    • 1994-10-13
    • PCT/JP1994000472
    • 1994-03-24
    • YAMANOUCHI PHARMACEUTICAL CO., LTD.HARA, RyuichiroITAHANA, HirotsuneSAKAMOTO, KenichiroHISAMICHI, HiroyukiNAGANO, Noriaki
    • YAMANOUCHI PHARMACEUTICAL CO., LTD.
    • C07D501/20
    • C07D501/00Y02P20/55
    • A cephalosporin derivative represented by general formula (I) or a salt thereof, wherein R represents hydrogen, lower alkenyl, lower alkynyl, cycloalkyl, hydroxyl-protecting group, or (un)substituted lower alkyl; R represents hydrogen, ester residue, or negative charge; R represents either (1) a group represented by general formula (a), wherein R and R represent each independently lower alkoxy or (un)substituted amino, or R and R may be combined together with the neighboring tetrahydropyridazine ring to form an (un)substituted fused 5- or 6-membered ring, or (2) a group represented by general formula (b) or (c), wherein R and R represent each independently hydrogen, halogen, amino, azido, carbamoyl, lower alkyl which may be substituted by amino, azido, carbamoyl or halogen, carbamoyl, or (un)substituted 5- or 6-membered heterocyclic group (provided the nitrogen atom of the heterocycle may be substituted to form a quaternary amine); X represents methine (-CH=) or nitrogen; and ring A represents a 4- to 5-membered nitrogenous heterocycle which may contain oxygen.
    • 由通式(I)表示的头孢菌素衍生物或其盐,其中R 1表示氢,低级烯基,低级炔基,环烷基,羟基保护基或(取代的)取代的低级烷基; R 2表示氢,酯残基或负电荷; R 3表示(1)由通式(a)表示的基团,其中R 4和R 5各自独立地代表低级烷氧基或(未)取代的氨基,或R 4和R 5 可以与相邻的四氢哒嗪环一起形成(未)取代的稠合的5元或6元环,或(2)由通式(b)或(c)表示的基团,其中R 6和 R 7各自独立地表示氢,卤素,氨基,叠氮基,氨基甲酰基,可以被氨基,叠氮基,氨基甲酰基或卤素取代的低级烷基,氨基甲酰基或(取代的)取代的5-或6-元杂环基团 杂环的氮原子可以被取代以形成季胺); X表示次甲基(-CH =)或氮; 环A表示可含有氧的4-至5-元含氮杂环。
    • 3. 发明申请
    • 5-HT3 RECEPTOR AGONIST, NOVEL THIAZOLE DERIVATIVE, AND INTERMEDIATE THEREFOR
    • 5-HT3受体激动剂,新型噻唑衍生物及其中间体
    • WO1995024399A1
    • 1995-09-14
    • PCT/JP1995000385
    • 1995-03-09
    • YAMANOUCHI PHARMACEUTICAL CO., LTD.IWAOKA, KiyoshiANAN, HidekiIMANISHI, NaokiKAZUTA, KenichiKOSHIO, HiroyukiSUZUKI, TakeshiITAHANA, HirotsuneITO, HiroyukiMIYATA, KeijiOHTA, Mitsuaki
    • YAMANOUCHI PHARMACEUTICAL CO., LTD.
    • C07D277/28
    • C07D277/60C07D417/04C07D417/06C07D417/14C07D471/04C07D471/08C07D487/04C07D487/08C07D513/04Y02P20/55
    • A 5-HT3 receptor agonist containing a thiazole derivative represented by general formula (I) as the active ingredient, a specified compound useful as a 5-HT3 receptor agonist, and a specified thioamide derivative useful as an intermediate therefor, wherein ring A represents one of the following rings which may be substituted by at least one substituent selected from the group consisting of halogen, lower alkyl and lower alkoxy: (1) a benzene ring, and (2) a 5- or 6-membered unsaturated heterocycle having one or two heteroatoms selected from among nitrogen, oxygen and sulfur; one of L and L represents a single bond, and the other of them is absent, or represents C1-C4 alkylene or C2-C5 alkenylene; R represents a group represented by any of general formulae: (1), (2), (3) and (4); L represents lower alkylene; L represents a single bond or lower alkylene; R and R represent each independently hydrogen, lower alkyl or an amino-protecting group; R represents hydrogen, lower alkyl, oxo or optionally protected amino; R is absent, or represents hydrogen, lower alkyl, aralkyl or an amino-protecting group; ring B represents one of the following rings which are either monocyclic or bicyclic and may bear an oxygen atom(s): (1) a nitrogenous saturated heterocycle bearing four to sixteen ring atoms, and (2) a nitrogenous heterocycle having a double bond and bearing four to sixteen ring atoms: and ring D represents a saturated carbocycle bearing four to eight ring atoms; provided the nitrogen atom of R may form an unsubstituted quaternary ammonium salt.
    • 含有由通式(I)表示的噻唑衍生物作为活性成分的5-HT 3受体激动剂,可用作5-HT 3受体激动剂的特定化合物和用作其中间体的特定硫代酰胺衍生物,其中环A表示1 可以被选自卤素,低级烷基和低级烷氧基的至少一个取代基取代的以下环:(1)苯环,和(2)具有一个或多个的一个或多个的5-或6-元不饱和杂环, 选自氮,氧和硫的两个杂原子; L 1和L 2之一表示单键,另一个不存在,或表示C1-C4亚烷基或C2-C5亚烯基; R表示由通式(1),(2),(3)和(4)中的任一个表示的基团。 L 3表示低级亚烷基; L 4代表单键或低级亚烷基; R 1和R 2各自独立地表示氢,低级烷基或氨基保护基; R 3表示氢,低级烷基,氧代或任选保护的氨基; R 4不存在,或表示氢,低级烷基,芳烷基或氨基保护基; 环B表示单环或双环的以下环之一,并且可以带有氧原子:(1)具有4至16个环原子的含氮饱和杂环,和(2)具有双键的含氮杂环和 具有四至十六个环原子:环D表示带有四至八个环原子的饱和碳环; 条件是R的氮原子可以形成未取代的季铵盐。
    • 4. 发明申请
    • METABOTROPIC GLUTAMATE RECEPTOR AGONISTS
    • 代谢谷氨酸受体激动剂
    • WO1998006724A1
    • 1998-02-19
    • PCT/JP1997002748
    • 1997-08-07
    • YAMANOUCHI PHARMACEUTICAL CO., LTD.HAYASHIBE, SatoshiITAHANA, HirotsuneYAHIRO, KiyoshiTSUKAMOTO, Shin-ichiOKADA, MasamichiYAMASHITA, Hiroshi
    • YAMANOUCHI PHARMACEUTICAL CO., LTD.
    • C07D513/04
    • C07D513/04A61K31/00A61K31/429
    • Medicinal compositions containing compounds represented by general formula (I) or pharmaceutically acceptable salts thereof having metabotropic glutamate receptor agonism and thus being useful as remedies for various diseases which can be cured or relieved thereby, in particular, epilepsy, pain, Parkinson's syndrome, etc.; the use of these compounds for producing these compositions; methods for treating the above-mentioned diseases through the administration of these compounds in effective dosages; and novel imidazobenzothiazole derivatives (II and III) or pharmaceutically acceptable salts thereof which are useful as remedies for the above-mentioned diseases, wherein the ring A represents an optionally substituted aryl, monocyclic heterocycle or dicyclic heterocycle group; R represents H, halogeno, lower alkyl, hydroxy(lower alkyl), lower alkoxy(lower alkyl) or lower alkoxy; R to R represent each a substituent selected from among various ones such as H, halogeno, lower alkyl, CN, NO2, alkoxy, thiol, carboxylate, sulfonate, carbamoyl, amine, substituted alkyl and heterocycles; R to R represent the same substituents as those of R to R excluding specific substituents and combinations thereof; and R represents hydroxymethyl, etc.
    • 含有由通式(I)表示的化合物或其药学上可接受的盐的代谢型谷氨酸受体激动剂的药用组合物,因此可用作可由其治愈或缓解的各种疾病,特别是癫痫,疼痛,帕金森综合症等的补救措施。 ; 这些化合物用于制备这些组合物的用途; 通过以有效剂量施用这些化合物来治疗上述疾病的方法; 和其可用作上述疾病的补救剂的新型咪唑并噻唑衍生物(II和III)或其药学上可接受的盐,其中环A表示任选取代的芳基,单环杂环或二环杂环基; R 1表示H,卤代,低级烷基,羟基(低级烷基),低级烷氧基(低级烷基)或低级烷氧基; R 2至R 5各自表示选自各种如H,卤代,低级烷基,CN,NO 2,烷氧基,硫醇,羧酸酯,磺酸酯,氨基甲酰基,胺,取代的烷基和杂环的取代基。 R 11至R 14代表与R 2至R 5相同的取代基,不包括特定取代基及其组合; R 13表示羟甲基等。